Home TRAD Events Doctors Decide Project Sign me up
Overview Global Vision VTE and Cancer News The Team Projects Publications Partners & Funders Patient Stories
Mail: TRADAlliance@cardiff.ac.uk
Home

Join our Newsletter

Name

Email (required)

TRAD Alliance Membership

1

Cancer patients are 7 times more likely to develop VTE. 2

2

10% of Patients with idiopathic VTE will harbour an Occult Cancer (NCBI.org)

3

Cancer is responsible for 18% of all cases of incident VTE.3

4

Some types of chemotherapy increase the risk of VTE, either by reducing the level of certain anticoagulants or by increasing the levels of pro coagulants.

5

In patients with high-grade glioma undergoing chemotherapy, the frequency of thromboembolic complications was as high as 16%. 4

6

Only 12% of patients with cancer and VTE survive beyond 1 year. 5

7

In patients with cancer, VTE is the second leading cause of death; in fact, of every seven patients with cancer who die while hospitalised, one will die of pulmonary embolism (PE). 3

8

VTE is found at autopsy in at least 50% of cancer patients. 6

9

The risk of VTE occurring after surgery is twice as high in cancer patients compared to non-cancer patients undergoing comparable surgery. 2

10

All cancer patients should be aware of the signs and symptoms of VTE and discuss preventative treatment with their doctor